While many psoriasis medications come as injections, apremilast is a psoriasis treatment that comes as a pill. If you can’t take any of these medications or you’ve tried them and they didn’t ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Humira was previously approved for psoriatic arthritis at a dose of one injection every other week. When the drug was approved for use in people coping with psoriasis, a dose was added which ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

and adults with chronic moderate-to-severe plaque psoriasis. In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR). This can occur in up to 49% of ...

Many concerns may arise following injection. The single most common ... does not recur with subsequent dosing. Each systemic psoriasis medication has its own adverse event profile.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Should you see any of these where you apply your psoriasis medication, contact your dermatologist. Is treatment that ...

Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...